The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Open accessAbstract
Ionizing radiation to a cancer site has the ability to convert the irradiated tumor in an immunogenic hub. However, radiation is a complex modifier of the tumor microenvironment and, by itself, is seldom sufficient to induce a therapeutically significant anti-tumor immune response, since it can also activate immune suppressive pathways. While several combinations of local radiation and immunotherapy have been shown in pre-clinical models to induce powerful anti-tumor immunity, the optimal strategy to achieve this effect remains to be defined. When used in vivo, radiation effects on tumors depend on the dose per fraction applied, the number of fractions used, and the total dose. Moreover, the interplay of these three variables is contingent upon the tumor setting studied, both in pre-clinical and clinical applications. To enable repair of the collateral damage to the normal tissue, radiation is usually given in multiple fractions, usually of 2 Gy. Generally, the use of larger fractions is limited to stereotactic applications, whereby optimal immobilization reduces inter- and intrafraction movement and permits a very conformal delivery of dose to the target, with optimal exclusion of normal tissue. Translation of the partnership of radiation and immunotherapy to the clinic requires a careful consideration of the radiation regimens used. To date, little is known on whether different dose/fractionation regimens have a specific impact on the anti-tumor immune response. Most experiments combining the two modalities were conducted with single fractions of radiotherapy. However, there is at least some evidencethat when combined with some specific immunotherapy approaches, the ability of radiation to promote anti-tumor immunity is dependent on the dose and fractionation employed. We critically review the available in vitro and in vivo data on this subject and discuss the potential impact of fractionation on the ability of radiation to synergize with immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 4×
“With the development of image-guided radiotherapy (IGRT) the uncertainty about the target volume is markedly reduced, permitting smaller and more conformal fields that reduce the inclusion of normal tissue and allow the delivery of larger single radiation doses with acceptable complications…”
BackgroundInfluentialNatural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,011
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Self-citationAutophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Systemic effects of local radiotherapy
Formenti, S. C., & Demaria, S. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70082-8 · Cited by 1,021
Self-citationLugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966
Tumor microenvironmental physiology and its implications for radiation oncology
Vaupel, P. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.008 · Cited by 947
Burnette, B. C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N. N., Weichselbaum, R. R., Fu, Y.-X., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 878
Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
Matsumura, S., Wang, B., Kawashima, N., Braunstein, S., Badura, M., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 711
Self-citationMaximizing Tumor Immunity With Fractionated Radiation
Schaue, D., Ratikan, J. A., Iwamoto, K. S., & McBride, W. H. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.049 · Cited by 567
Garnett, C. T., Palena, C., Chakarborty, M., Tsang, K.-Y., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1525 · Cited by 557
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., Kim, Y. H., Hoppe, R. T., Knox, S. J., Shin, L. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9793 · Cited by 487
Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity
Lugade, A. A., Sorensen, E. W., Gerber, S. A., Moran, J. P., Frelinger, J. G., & Lord, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3132 · Cited by 485
Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474
Chakraborty, M., Abrams, S. I., Camphausen, K., Liu, K., Scott, T., Coleman, C. N., & Hodge, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6338 · Cited by 467
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.
Hallahan, D. E., Spriggs, D. R., Beckett, M. A., Kufe, D. W., & Weichselbaum, R. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10104 · Cited by 464
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
Wrzesinski, S. H., Wan, Y. Y., & Flavell, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1157 · Cited by 452
Chakraborty, M., Abrams, S. I., Coleman, C. N., Camphausen, K., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0073 · Cited by 435
Transforming growth factor-beta activation in irradiated murine mammary gland.
Barcellos-Hoff, M. H., Derynck, R., Tsang, M. L., & Weatherbee, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117045 · Cited by 431
Radiation Enhances Regulatory T Cell Representation
Kachikwu, E. L., Iwamoto, K. S., Liao, Y.-P., DeMarco, J. J., Agazaryan, N., Economou, J. S., McBride, W. H., & Schaue, D. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.034 · Cited by 429
Innovations in image-guided radiotherapy
Verellen, D., Ridder, M. D., Linthout, N., Tournel, K., Soete, G., & Storme, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2288 · Cited by 384
Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marte, J., Beetham, P., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370
Regnier, R. (1992) · PubMed · Cited by 362
Amundson, S. A., Bittner, M., Chen, Y., Trent, J., Meltzer, P., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202676 · Cited by 338
A Sense of Danger from Radiation1
McBride, W. H., Chiang, C.-S., Olson, J. L., Wang, C.-C., Hong, J.-H., Pajonk, F., Dougherty, G. J., Iwamoto, K. S., Pervan, M., & Liao, Y.-P. (2004) · Radiation Research · doi:10.1667/rr3196 · Cited by 323
Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
Formenti, S. C., & Demaria, S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.06.020 · Cited by 319
Self-citationWithers, H. R. (1975) · Advances in Radiation Biology · doi:10.1016/b978-0-12-035405-4.50012-8 · Cited by 303
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
Seung, S. K., Curti, B. D., Crittenden, M., Walker, E., Coffey, T., Siebert, J. C., Miller, W., Payne, R., Glenn, L., Bageac, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003649 · Cited by 303
Jobling, M. F., Mott, J. D., Finnegan, M. T., Jurukovski, V., Erickson, A. C., Walian, P. J., Taylor, S. E., Ledbetter, S., Lawrence, C. M., Rifkin, D. B., et al. (2006) · Radiation Research · doi:10.1667/rr0695.1 · Cited by 300
Steel, G. G., McMillan, T. J., & Peacock, J. H. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914552491 · Cited by 290
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis
Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., et al. (1998) · Gut · doi:10.1136/gut.43.4.575 · Cited by 277
(1979) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/63.5.1229 · Cited by 263
Tsai, C.-S., Chen, F.-H., Wang, C.-C., Huang, H.-L., Jung, S.-M., Wu, C.-J., Lee, C.-C., McBride, W. H., Chiang, C.-S., & Hong, J.-H. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.041 · Cited by 257
Amundson, S. A., Do, K. T., Vinikoor, L. C., Lee, R. A., Koch-Paiz, C. A., Ahn, J., Reimers, M., Chen, Y., Scudiero, D. A., Weinstein, J. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2120 · Cited by 253
Wersäll, P. J., Blomgren, H., Pisa, P., Lax, I., Kälkner, K.-M., & Svedman, C. (2006) · Acta Oncologica · doi:10.1080/02841860600604611 · Cited by 233
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00649.x · Cited by 229
Barcellos‐Hoff, M. H. (1993) · PubMed · Cited by 209
Tsai, M.-H., Cook, J. A., Chandramouli, G. V. R., DeGraff, W., Yan, H., Zhao, S., Coleman, C. N., Mitchell, J. B., & Chuang, E. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4250 · Cited by 200
Kim, J.-Y., Son, Y.-O., Park, S.-W., Bae, J.-H., Chung, J. S., Kim, H. H., Chung, B.-S., Kim, S.-H., & Kang, C.-D. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.56 · Cited by 195
Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
Ruocco, M. G., Pilones, K. A., Kawashima, N., Cammer, M., Huang, J., Babb, J. S., Liu, M., Formenti, S. C., Dustin, M. L., & Demaria, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61931 · Cited by 187
Self-citationRadiation-Induced Pulmonary Fibrosis: Examination of Chemokine and Chemokine Receptor Families
Johnston, C. J., Williams, J. P., Okunieff, P., & Finkelstein, J. N. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0256:ripfeo]2.0.co;2 · Cited by 178
Newcomb, E. W., Demaria, S., Lukyanov, Y., Shao, Y., Schnee, T., Kawashima, N., Lan, L., Dewyngaert, J. K., Zagzag, D., McBride, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0593 · Cited by 166
Self-citationGAUGLER, C. S. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143428 · Cited by 163
Matsumura, S., & Demaria, S. (2010) · Radiation Research · doi:10.1667/rr1860.1 · Cited by 160
Self-citationThe immunologic constant of rejection
Wang, E., Worschech, A., & Marincola, F. M. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.03.002 · Cited by 158
Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines
Barker, B. R., Taxman, D. J., & Ting, J. P. ‐. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.005 · Cited by 130
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice
Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125
Sensors of ionizing radiation effects on the immunological microenvironment of cancer
Demaria, S., & Formenti, S. C. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701481816 · Cited by 123
Self-citationImmune selective pressure and HLA class I antigen defects in malignant lesions
Chang, C., & Ferrone, S. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0183-1 · Cited by 117
Abscopal effect of radiation in papillary adenocarcinoma
Ehlers, G., & Fridman, M. (1973) · British Journal of Radiology · doi:10.1259/0007-1285-46-543-220 · Cited by 116
The Evolving Role of Radiation Therapy in the Management of Malignant Melanoma
Khan, N., Khan, M. K., Almasan, A., Singh, A. D., & Macklis, R. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.071 · Cited by 78
Petrovski, G., Duran, G. A., Majai, G. E., Hodrea, J., Benkő, S., Mádi, A., & Fésüs, L. (2011) · Autophagy · doi:10.4161/auto.7.3.14583 · Cited by 65
Local control by radiotherapy: is that all there is?
Formenti, S. C., & Demaria, S. (2008) · Breast Cancer Research · doi:10.1186/bcr2160 · Cited by 65
Self-citationHauser, S. H., Calorini, L., Wazer, D. E., & Gattoni‐Celli, S. (1993) · PubMed · Cited by 63
Fractionated Radiation Therapy Can Induce a Molecular Profile for Therapeutic Targeting
John‐Aryankalayil, M., Palayoor, S. T., Cerna, D., Simone, C. B., Falduto, M. T., Magnuson, S. R., & Coleman, C. N. (2010) · Radiation Research · doi:10.1667/rr2105.1 · Cited by 56
A genetic inference on cancer immune responsiveness
Wang, E., Uccellini, L., & Marincola, F. M. (2012) · OncoImmunology · doi:10.4161/onci.19531 · Cited by 36
Regulatory T Cells in γ Irradiation-Induced Immune Suppression
McFarland, H. I., Puig, M., Grajkowska, L. T., Tsuji, K., Lee, J. P., Mason, K. P., Verthelyi, D. I., & Rosenberg, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039092 · Cited by 32
Chu, K., Leonhardt, E. A., Trinh, M., Prieur-Carrillo, G., Lindqvist, J., Albright, N., Ling, C., & Dewey, W. C. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0667:cvtlca]2.0.co;2 · Cited by 30
Cited by
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
Self-citationAdams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Self-citationRadiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum, R. R., Liang, H., Deng, L., & Fu, Y.-X. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,070
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Metadata
- Authors
- Demaria, S., & Formenti, S. C.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 2
- Pages
- 153-153
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2115964409
- Cited by
- 332
- References
- 67
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.